Survey and Detection of Hepatitis C Virus in a Population and Management of Hepatitis C Virus Carriers
|
Accession number;03A0333113
|
| Title;Survey and Detection of Hepatitis C Virus in a Population and Management of Hepatitis C Virus Carriers |
| Author;
ABE KOICHI
(Iwate Medical Univ., School of Medicine, JPN)
SUZUKI KAZUYUKI
(Iwate Medical Univ., School of Medicine, JPN)
KASAI YUKIHO
(Iwate Medical Univ., School of Medicine, JPN)
KUMAGAI ICHIRO
(Iwate Medical Univ., School of Medicine, JPN)
OKANO TSUGUHIKO
(Iwate Medical Univ., School of Medicine, JPN)
MIYASAKA AKIO
(Iwate Medical Univ., School of Medicine, JPN)
SAINOKAMI SHIGEHIKO
(Iwate Medical Univ., School of Medicine, JPN)
KOYAMA TOMIKO
(Iwate Health Serv. Assoc., JPN)
|
Journal Title;Prog Med
|
Journal Code:F0664B
|
ISSN:0287-3648
|
|
VOL.23;NO.4;PAGE.1059-1064(2003)
|
| Figure&Table&Reference;FIG.7, TBL.3, REF.10 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Hepatocellular carcinoma (HCC), the incidence of which has been increasing, is commonly observed among hepatitis C virus (HCV) carriers. The inhibition of disease progress in HCV carriers is the most effective means to prevent the development of HCC. There are many HCV carriers with normal serum ALT levels and without exhibiting any symptoms. It is, therefore, important to examine a population for HCV and to identify HCV carriers. When the natural course of serum ALT levels was observed in HCV carriers with normal serum ALT levels at the first examination of the population, which accounted for 70% of HCV carriers examined, serum ALT levels fluctuated outside the normal range in approximately 48% of HCV carriers during the 10-year follow-up. It is necessary to establish a periodic follow-up system for HCV carriers and to administer medical treatment according to the state of the disease. (author abst.) |
|
|
|
Related Articles;
|
|
